Aurore Morello

Research Scholar

Office Phone

212-639-8158

Email

morelloa@mskcc.org

Start Year

2013

Publications

Manuscripts

Abstracts/Presentations

  • Morello A, Villena-Vargas J, Mayor M, Bograd AJ, Jones DR, Sadelain M,  Adusumilli PS. Mesothelin-Targeted CAR T-Cell Therapy for the Treatment of Heterogeneous Antigen-Expressing Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Mayor M, Villena-Vargas J, de Biasi A, Morello A, Jones DR, Sadelain M, Adusumilli PS. Tumor-Targeted Radiation Therapy Helps Overcome the Solid Tumor T-Cell Infiltration Barrier and Promotes Mesothelin CAR T-Cell Therapy. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Ujiie H, Morello A, Kadota K, Buitrago DH, Woo K, Jones DR, Travis WD, Sadelain M, Adusumilli PS. Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Cherkassky L, Morello A, Villena-Vargas J, Mayor M, Jones DR, Sadelain M, Adusumilli PS. Genetic-Engineering Strategies to Enhance CAR T-Cell Therapy Efficacy against PD-L1 Expressing Lung Adenocarcinoma and Mesothelioma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Roldan C, Morello A, Adusumilli PS. Immunotherapeutic T-cell engineering techniques targeting solid tumors. 37th Annual Memorial Sloan-Kettering Cancer Center Medical Student Summer Fellowship Program Poster Presentation. August 14, 2014; New York, NY.